Which precaution is correct regarding migraine management in pregnancy?

Which precaution is correct regarding migraine management in pregnancy?

• A. Valproate should be avoided during pregnancy due to fetal risks.
• B. Valproate is recommended as first-line in pregnancy
• C. Triptans are contraindicated in pregnancy
• D. Ergot alkaloids are preferred during pregnancy

Answer: (A)

When managing migraines in pregnancy, the safety of the fetus is the top priority, because some migraine medications carry significant teratogenic risks. Valproate stands out as strongly teratogenic, with well-established associations with neural tube defects and later neurodevelopmental problems. Because of this, valproate should be avoided in pregnancy and for women who could become pregnant, with a switch to safer alternatives if pregnancy occurs. That’s why this precaution is the best answer. Other options don’t fit as well. Valproate is not recommended as first-line therapy in pregnancy due to fetal risks. Ergot alkaloids are avoided in pregnancy because their potent vasoconstrictive effects can compromise uteroplacental blood flow and raise the risk of miscarriage and fetal distress. Triptans are not categorically contraindicated in pregnancy; they can be used when benefits outweigh risks under medical supervision, rather than being strictly avoided.

When managing migraines in pregnancy, the safety of the fetus is the top priority, because some migraine medications carry significant teratogenic risks. Valproate stands out as strongly teratogenic, with well-established associations with neural tube defects and later neurodevelopmental problems. Because of this, valproate should be avoided in pregnancy and for women who could become pregnant, with a switch to safer alternatives if pregnancy occurs. That’s why this precaution is the best answer.

Other options don’t fit as well. Valproate is not recommended as first-line therapy in pregnancy due to fetal risks. Ergot alkaloids are avoided in pregnancy because their potent vasoconstrictive effects can compromise uteroplacental blood flow and raise the risk of miscarriage and fetal distress. Triptans are not categorically contraindicated in pregnancy; they can be used when benefits outweigh risks under medical supervision, rather than being strictly avoided.